LGALS3 and breast cancer: Elevated levels of Gal-3 are typically associated with a pro-metastatic tumour phenotype; however, Pereira et al. have reported that reduced Gal-3 expression during breast cancer progression correlated with increased metastasis of 4T1 murine breast cancer cells to the bone marrow.77